• News
  • SAN DIEGO
  • Health

True Diagnostics, Merck KGaA collaborate to improve thyroid care in China

Carlsbad-based True Diagnostics Inc. has entered into a collaboration with Merck KGaA in Darmstadt, Germany, a world leader in providing cardiometabolic care.

Under the agreement, True Diagnostics will collaborate with the biopharmaceutical division of Merck KGaA, which operates as EMD Serono in the United States and Canada, to help improve and increase access to thyroid care in the People's Republic of China.

The partnership allows the companies to provide medical professionals with a new and meaningful point-of-care method for rapid screening of hypothyroidism patients in minutes using only a small sample of whole-blood collected directly from the patient's fingertip.

Under the terms of the partnership, Merck KGaA will have the exclusive right to market and distribute True Diagnostics' proprietary screening assay platform and associated consumables in the thyroid care market in China. True Diagnostics received clearance in China from the China Food and Drug Administration for their TrueDX Platform and TSH (Thyroid Stimulating Hormone) test.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.